Safety and pharmacokinetics of first-line amg 479 (mab to igf1r) or amg 102 (mab to hgf/sf) with platinum-based chemotherapy in extensive-stage small cell lung cancer (sclc)

P. Lorigan; J. Soria; J. Stephenson; A. Maru; R. Gervais; M. Zhu; I. McCaffery; Y. Jiang; J. McGreivy; B. Glisson

Safety and pharmacokinetics of first-line amg 479 (mab to igf1r) or amg 102 (mab to hgf/sf) with platinum-based chemotherapy in extensive-stage small cell lung cancer (sclc)

P. Lorigan, J. Soria, J. Stephenson, A. Maru, R. Gervais, M. Zhu, I. McCaffery, Y. Jiang, J. McGreivy, B. Glisson

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	149-149
Number of pages	1
Journal	Annals of Oncology
Volume	21
Issue number	Supplement 8
Publication status	Published - Oct 2010
Event	ESMO 2010 Congress - Milan, Italy Duration: 8 Oct 2010 → 12 Oct 2010 https://www.esmo.org/meetings/past-meetings/esmo-2010-congress-milan

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{2bef0a0e6515462db2f0345075e4374d,

title = "Safety and pharmacokinetics of first-line amg 479 (mab to igf1r) or amg 102 (mab to hgf/sf) with platinum-based chemotherapy in extensive-stage small cell lung cancer (sclc)",

author = "P. Lorigan and J. Soria and J. Stephenson and A. Maru and R. Gervais and M. Zhu and I. McCaffery and Y. Jiang and J. McGreivy and B. Glisson",

year = "2010",

month = oct,

language = "English",

volume = "21",

pages = "149--149",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier BV",

number = "Supplement 8",

note = "ESMO 2010 Congress ; Conference date: 08-10-2010 Through 12-10-2010",

url = "https://www.esmo.org/meetings/past-meetings/esmo-2010-congress-milan",

}

Safety and pharmacokinetics of first-line amg 479 (mab to igf1r) or amg 102 (mab to hgf/sf) with platinum-based chemotherapy in extensive-stage small cell lung cancer (sclc). / Lorigan, P.; Soria, J.; Stephenson, J. et al.
In: Annals of Oncology, Vol. 21, No. Supplement 8, 10.2010, p. 149-149.

Research output: Contribution to journal › Meeting Abstract › peer-review

TY - JOUR

T1 - Safety and pharmacokinetics of first-line amg 479 (mab to igf1r) or amg 102 (mab to hgf/sf) with platinum-based chemotherapy in extensive-stage small cell lung cancer (sclc)

AU - Lorigan, P.

AU - Soria, J.

AU - Stephenson, J.

AU - Maru, A.

AU - Gervais, R.

AU - Zhu, M.

AU - McCaffery, I.

AU - Jiang, Y.

AU - McGreivy, J.

AU - Glisson, B.

PY - 2010/10

Y1 - 2010/10

UR - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000283115900459&KeyUID=WOS:000283115900459

M3 - Meeting Abstract

SN - 0923-7534

VL - 21

SP - 149

EP - 149

JO - Annals of Oncology

JF - Annals of Oncology

IS - Supplement 8

T2 - ESMO 2010 Congress

Y2 - 8 October 2010 through 12 October 2010

ER -

Safety and pharmacokinetics of first-line amg 479 (mab to igf1r) or amg 102 (mab to hgf/sf) with platinum-based chemotherapy in extensive-stage small cell lung cancer (sclc)

UN SDGs

Other files and links

Cite this